4.7 Review

Nanotechnology approaches in the current therapy of skin cancer

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 153, Issue -, Pages 109-136

Publisher

ELSEVIER
DOI: 10.1016/j.addr.2020.02.005

Keywords

Melanoma skin cancer; Nonmelanoma skin cancer; Nanocarrier design; Drug delivery systems; Multifunctional delivery systems; Immunotherapy; Gene therapy

Funding

  1. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp, Brazil) [2014/50928-2]
  2. Conselho Nacional de Pesquisa (CNPQ Brazil) [465687/2014-8]
  3. European Commission under Horizon 2020's Marie Sklodowska-Curie Actions COFUND scheme, Spain [712754]
  4. Severo Ochoa programme of the Spanish Ministry of Science and Competitiveness [SEV-2014-0425 (2015-2019)]
  5. FAPESP-Brazil [2019/04448-2]
  6. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [19/04448-2, 14/50928-2] Funding Source: FAPESP

Ask authors/readers for more resources

Skin cancer is a high burden disease with a high impact on global health. Conventional therapies have several drawbacks; thus, the development of effective therapies is required. In this context, nanotechnology approaches are an attractive strategy for cancer therapy because they enable the efficient delivery of drugs and other bioactive molecules to target tissues with low toxic effects. In this review, nanotechnological tools for skin cancer will be summarized and discussed. First, pathology and conventional therapies will be presented, followed by the challenges of skin cancer therapy. Then, the main features of developing efficient nanosystems will be discussed, and next, the most commonly used nanoparticles (NPs) described in the literature for skin cancer therapy will presented. Subsequently, the use of NPs to deliver chemotherapeutics, immune and vaccine molecules and nucleic acids will be reviewed and discussed as will the combination of physical methods and NPs. Finally, multifunctional delivery systems to codeliver anticancer therapeutic agents containing or not surface functionalization will be summarized. (c) 2020 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available